Literature DB >> 3296871

Lung liquid and protein exchange: the four inhomogeneities.

N C Staub.   

Abstract

William of Ockham, 14th-century scholastic philosopher at Oxford and Munich, emphasized the principle of economy, "pleurality is not to be supposed without necessity" (Ockham's razor). Necessity is the key word. In the modeling of steady-state lung liquid and protein exchange, the desire for simplicity has sometimes outweighed good judgment. In fact, we and others have shown that simple models do not work. It is necessary to include several forms of inhomogeneity. The air-filled lung shows regional (top to bottom) variations of mass, microvascular pressure, and perimicrovascular protein concentration. Normally, the small longitudinal (arterioles to venules) gradient of microvascular and perimicrovascular pressures is not a major concern, but in nonuniform disease processes, such as microembolism, longitudinal inhomogeneity, and parallel inhomogeneity are dominant. Multiple pores should also be considered a form of inhomogeneity. The effect on liquid and protein exchange, when plasma protein concentration or microvascular pressure change, can be readily explained using pore heterogeneity. The model I am currently using consists of a large number of discrete compartments (18), rather than a continuous distribution. We have recently identified a fifth inhomogeneity, which is that lung lymph flow might not always represent steady-state transvascular filtration because interstitial liquid may leak through the pleura or along the bronchovascular liquid cuffs into the mediastinum.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3296871     DOI: 10.1007/BF02364048

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  31 in total

1.  General continuum analysis of transport through pores. I. Proof of Onsager's reciprocity postulate for uniform pore.

Authors:  D G Levitt
Journal:  Biophys J       Date:  1975-06       Impact factor: 4.033

2.  Pulmonary vascular transport in sheep. A mathematical model.

Authors:  L H Blake; N C Staub
Journal:  Microvasc Res       Date:  1976-09       Impact factor: 3.514

3.  Effects of prolonged elevated microvascular pressure on lung fluid balance in sheep.

Authors:  R E Parker; R J Roselli; K L Brigham
Journal:  J Appl Physiol (1985)       Date:  1985-03

4.  Quantification of damage by air emboli to lung microvessels in anesthetized sheep.

Authors:  K H Albertine; J P Wiener-Kronish; K Koike; N C Staub
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1984-11

5.  Extra-alveolar vessel fluid filtration coefficients in excised and in situ canine lobes.

Authors:  R K Albert; W Kirk; C Pitts; J Butler
Journal:  J Appl Physiol (1985)       Date:  1985-11

6.  Venous air emboli in sheep: reversible increase in lung microvascular permeability.

Authors:  K Ohkuda; K Nakahara; A Binder; N C Staub
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1981-10

7.  Direct measurement of microvascular pressures in the isolated perfused dog lung.

Authors:  J Bhattacharya; N C Staub
Journal:  Science       Date:  1980-10-17       Impact factor: 47.728

8.  A theoretical model of protein, fluid, and small molecule transport in the lung.

Authors:  T R Harris; R J Roselli
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1981-01

9.  Dynamics of capillary fluid exchange: a nonlinear computer simulation.

Authors:  C A Wiederhielm
Journal:  Microvasc Res       Date:  1979-07       Impact factor: 3.514

10.  Effect of increased vascular pressure on lung fluid balance in unanesthetized sheep.

Authors:  A J Erdmann; T R Vaughan; K L Brigham; W C Woolverton; N C Staub
Journal:  Circ Res       Date:  1975-09       Impact factor: 17.367

View more
  1 in total

1.  Superoxide anion mediates pulmonary vascular permeability caused by neutrophils in cardiopulmonary bypass.

Authors:  T Tanita; C Song; H Kubo; Y Hoshikawa; M Chida; S Suzuki; S Ono; S Fujimura
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.